BAM
CNCR

Belpointe Asset Management’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Belpointe Asset Management’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-460
Closed -$6.32K – 3744
2022
Q4 		$6.32K Buy
+460
New +$6.32K ﹤0.01% 2829